Yang JW - Search Results

1

Discovery of novel 2,5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62.

Park JH, Lee GE, Lee SD, Hien TT, Kim S, Yang JW, Cho JH, Ko H, Lim SC, Kim YG, Kang KW, Kim YC. Park JH, et al. Among authors: yang jw. J Med Chem. 2015 Mar 12;58(5):2114-34. doi: 10.1021/jm500324g. Epub 2015 Feb 23. J Med Chem. 2015. PMID: 25597334

2

Nectandrin B suppresses the expression of adhesion molecules in endothelial cells: Role of AMP-activated protein kinase activation.

Hien TT, Ki SH, Yang JW, Oh WK, Kang KW. Hien TT, et al. Among authors: yang jw. Food Chem Toxicol. 2014 Apr;66:286-94. doi: 10.1016/j.fct.2014.01.052. Epub 2014 Feb 8. Food Chem Toxicol. 2014. PMID: 24518543

3

Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation.

Yang JW, Hien TT, Lim SC, Jun DW, Choi HS, Yoon JH, Cho IJ, Kang KW. Yang JW, et al. J Hepatol. 2014 Jun;60(6):1235-41. doi: 10.1016/j.jhep.2014.02.004. Epub 2014 Feb 13. J Hepatol. 2014. PMID: 24530597

4

Potent inhibition of the inductions of inducible nitric oxide synthase and cyclooxygenase-2 by taiwaniaflavone.

Pokharel YR, Yang JW, Kim JY, Oh HW, Jeong HG, Woo ER, Kang KW. Pokharel YR, et al. Among authors: yang jw. Nitric Oxide. 2006 Nov;15(3):217-25. doi: 10.1016/j.niox.2006.01.001. Epub 2006 Feb 20. Nitric Oxide. 2006. PMID: 16488167

5

Bifunctional effects of fucoidan on the expression of inducible nitric oxide synthase.

Yang JW, Yoon SY, Oh SJ, Kim SK, Kang KW. Yang JW, et al. Biochem Biophys Res Commun. 2006 Jul 21;346(1):345-50. doi: 10.1016/j.bbrc.2006.05.135. Epub 2006 Jun 2. Biochem Biophys Res Commun. 2006. PMID: 16756944

6

Inhibition of inducible nitric oxide synthase by sumaflavone isolated from Selaginella tamariscina.

Yang JW, Pokharel YR, Kim MR, Woo ER, Choi HK, Kang KW. Yang JW, et al. J Ethnopharmacol. 2006 Apr 21;105(1-2):107-13. doi: 10.1016/j.jep.2005.10.001. Epub 2005 Nov 10. J Ethnopharmacol. 2006. PMID: 16289413

7

GPR119: a promising target for nonalcoholic fatty liver disease.

Yang JW, Kim HS, Im JH, Kim JW, Jun DW, Lim SC, Lee K, Choi JM, Kim SK, Kang KW. Yang JW, et al. FASEB J. 2016 Jan;30(1):324-35. doi: 10.1096/fj.15-273771. Epub 2015 Sep 23. FASEB J. 2016. PMID: 26399788

8

Inhibition of nuclear factor-kappaB activation by 2',8''-biapigenin.

Woo ER, Pokharel YR, Yang JW, Lee SY, Kang KW. Woo ER, et al. Among authors: yang jw. Biol Pharm Bull. 2006 May;29(5):976-80. doi: 10.1248/bpb.29.976. Biol Pharm Bull. 2006. PMID: 16651730 Free article.

9

Therapeutic application of GPR119 ligands in metabolic disorders.

Yang JW, Kim HS, Choi YW, Kim YM, Kang KW. Yang JW, et al. Diabetes Obes Metab. 2018 Feb;20(2):257-269. doi: 10.1111/dom.13062. Epub 2017 Aug 22. Diabetes Obes Metab. 2018. PMID: 28722242 Review.

10

Induction of E6AP by microRNA-302c dysregulation inhibits TGF-β-dependent fibrogenesis in hepatic stellate cells.

Kim JY, Kim KM, Yang JH, Cho SS, Kim SJ, Park SJ, Ahn SG, Lee GH, Yang JW, Lim SC, Kang KW, Ki SH. Kim JY, et al. Among authors: yang jh, yang jw. Sci Rep. 2020 Jan 16;10(1):444. doi: 10.1038/s41598-019-57322-w. Sci Rep. 2020. PMID: 31949242 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,282 results

Search Page

Filters